This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses
The product is expected to start contributing meaningfully to the revenue from FY25
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
The hospital hosted a two-day event with top internal and external faculty and medical experts
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Mpower an initiative of Aditya Birla Education Trust works in the space of Mental health
The brand has launched 6 new range of products to provide a complete pregnancy care solution
Subscribe To Our Newsletter & Stay Updated
